BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 7989947)

  • 1. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma.
    Picci P; Sangiorgi L; Rougraff BT; Neff JR; Casadei R; Campanacci M
    J Clin Oncol; 1994 Dec; 12(12):2699-705. PubMed ID: 7989947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?
    Reddy KI; Wafa H; Gaston CL; Grimer RJ; Abudu AT; Jeys LM; Carter SR; Tillman RM
    Bone Joint J; 2015 Jan; 97-B(1):115-20. PubMed ID: 25568424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification.
    Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR
    Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experience.
    Gherlinzoni F; Picci P; Bacci G; Campanacci D
    Ann Oncol; 1992 Apr; 3 Suppl 2():S23-7. PubMed ID: 1622858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do Surgical Margins Affect Local Recurrence and Survival in Extremity, Nonmetastatic, High-grade Osteosarcoma?
    Bertrand TE; Cruz A; Binitie O; Cheong D; Letson GD
    Clin Orthop Relat Res; 2016 Mar; 474(3):677-83. PubMed ID: 26013153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma.
    Sluga M; Windhager R; Lang S; Heinzl H; Bielack S; Kotz R
    Clin Orthop Relat Res; 1999 Jan; (358):120-7. PubMed ID: 9973983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
    Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcomes and prognostic factors of non-metastatic radiation-induced sarcoma of bone.
    Tsuda Y; Lowe M; Evans S; Parry MC; Stevenson JD; Fujiwara T; Kaneuchi Y; Le Nail LR; Jeys LM
    Eur J Surg Oncol; 2020 Feb; 46(2):293-298. PubMed ID: 31703834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.
    Tabone MD; Kalifa C; Rodary C; Raquin M; Valteau-Couanet D; Lemerle J
    J Clin Oncol; 1994 Dec; 12(12):2614-20. PubMed ID: 7989936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
    Bacci G; Picci P; Pignatti G; De Cristofaro R; Dallari D; Avella M; Manfrini M; Marangolo M; Ferruzzi A; Mercuri M
    Clin Orthop Relat Res; 1991 Sep; (270):87-98. PubMed ID: 1884564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Dissection and Preservation of Adherent Popliteal Vessels From a Posterior Soft Tissue Mass Associated With a Higher Proportion of Local Recurrence in Patients With a Distal Femoral Osteosarcoma?
    Ebeid W; Elghoneimy A; Abousenna W
    Clin Orthop Relat Res; 2023 Nov; 481(11):2167-2176. PubMed ID: 37527334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).
    Rodriguez-Galindo C; Shah N; McCarville MB; Billups CA; Neel MN; Rao BN; Daw NC
    Cancer; 2004 May; 100(9):1928-35. PubMed ID: 15112274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
    Xie L; Guo W; Li Y; Ji T; Sun X
    J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-arterial cisplatin given prior to surgery in osteosarcoma: grade of necrosis and size of tumor as major prognostic factors.
    Quintana J; Beresi V; DelPozo H; Latorre JJ; Henriquez A; Chamas N; Diaz V; Geldres V; Sepulveda L; Macho L
    Am J Pediatr Hematol Oncol; 1991; 13(3):269-73. PubMed ID: 1793151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center.
    Tomer G; Cohen IJ; Kidron D; Katz K; Yosipovitch Z; Meller I; Zaizov R
    Int J Oncol; 1999 Jul; 15(1):179-85. PubMed ID: 10375613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of osteosarcoma treated by limb-salvage surgery: the ten-year intergroup study in Japan.
    Tsuchiya H; Tomita K
    Jpn J Clin Oncol; 1992 Oct; 22(5):347-53. PubMed ID: 1469796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery.
    Loh AH; Navid F; Wang C; Bahrami A; Wu J; Neel MD; Rao BN
    Ann Surg Oncol; 2014 Jun; 21(6):1948-55. PubMed ID: 24558066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zürich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA).
    Honegger HP; Cserhati MD; Exner GU; von Hochstetter A; Groscurth P
    Ann Oncol; 1991 Jul; 2(7):489-94. PubMed ID: 1911456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients.
    Bacci G; Longhi A; Cesari M; Versari M; Bertoni F
    Cancer; 2006 Jun; 106(12):2701-6. PubMed ID: 16691623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.